Literature DB >> 14959890

The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells.

Nannan Yang1, Morten B Strøm, Seble M Mekonnen, John S Svendsen, Oystein Rekdal.   

Abstract

A number of shortened derivatives of the lactoferrin model peptide L12, PAWRKAFRWAKRMLKKAA, were designed in order to elucidate the structural basis for antitumour activity of lactoferrin derivatives. Three tumour cell lines were included in the study and toxicity determined by measuring lysis of human red blood cells and fibroblasts. The results demonstrated a strong correlation between antitumour activity and net positive charge, in which a net charge close to +7 was essential for a high antitumour activity. In order to increase the antitumour activity of the shortest peptide with a net charge less than +7, the hydrophobicity had to be increased by adding a bulky Trp residue. None of the peptides were haemolytic, but toxicity against fibroblasts was observed. However, modifications of the peptides had a higher effect on reducing fibroblast toxicity than antitumour activity and thereby resulted in peptides displaying an almost 7-fold selectivity for tumour cells compared with fibroblasts. The antimicrobial activity against the Gram-negative bacteria Escherichia coil and the Gram-positive bacteria Staphylococcus aureus was also included in order to compare the structural requirements for antitumour activity with those required for a high antimicrobial activity. The results showed that most of the peptides were highly active against both bacterial strains. Less modification by shortening the peptide sequences was tolerated for maintaining a high antitumour activity and selectivity compared with antimicrobial activity. The order of the amino acid residues and thereby the conformation of the peptides was highly essential for antitumour activity, whereas the antimicrobial activity was hardly influenced by changes in this parameter. Thus, in addition to a certain net positive charge and hydrophobicity, the ability to adopt an amphipathic conformation was a more critical structural parameter for antitumour activity than for antimicrobial activity, and implied that a higher flexibility or number of active conformations was tolerated for the peptides to exert a high antimicrobial activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14959890     DOI: 10.1002/psc.470

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  17 in total

1.  Studies on lactoferricin-derived Escherichia coli membrane-active peptides reveal differences in the mechanism of N-acylated versus nonacylated peptides.

Authors:  Dagmar Zweytick; Günter Deutsch; Jörg Andrä; Sylvie E Blondelle; Ekkehard Vollmer; Roman Jerala; Karl Lohner
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  A peptide domain of bovine milk lactoferrin inhibits the interaction between streptococcal surface protein antigen and a salivary agglutinin peptide domain.

Authors:  Takahiko Oho; Floris J Bikker; Arie V Nieuw Amerongen; Jasper Groenink
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 3.  Peptide antimicrobial agents.

Authors:  Håvard Jenssen; Pamela Hamill; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

Review 4.  Studies on anticancer activities of antimicrobial peptides.

Authors:  David W Hoskin; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2007-11-22

5.  Peptide-functionalized poly(ethylene glycol) star polymers: DNA delivery vehicles with multivalent molecular architecture.

Authors:  Katye M Fichter; Le Zhang; Kristi L Kiick; Theresa M Reineke
Journal:  Bioconjug Chem       Date:  2007-10-04       Impact factor: 4.774

6.  Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells.

Authors:  Bodil Fadnes; Lars Uhlin-Hansen; Inger Lindin; Øystein Rekdal
Journal:  BMC Cancer       Date:  2011-03-31       Impact factor: 4.430

Review 7.  Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs.

Authors:  Sabrina Riedl; Dagmar Zweytick; Karl Lohner
Journal:  Chem Phys Lipids       Date:  2011-09-16       Impact factor: 3.329

8.  Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.

Authors:  Ketil André Camilio; Gerd Berge; Chandra Sekhar Ravuri; Oystein Rekdal; Baldur Sveinbjørnsson
Journal:  Cancer Immunol Immunother       Date:  2014-03-28       Impact factor: 6.968

9.  Potential anticarcinogenic peptides from bovine milk.

Authors:  Giacomo Pepe; Gian Carlo Tenore; Raffaella Mastrocinque; Paola Stusio; Pietro Campiglia
Journal:  J Amino Acids       Date:  2013-02-26

10.  Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine.

Authors:  Sabrina Riedl; Beate Rinner; Helmut Schaider; Karl Lohner; Dagmar Zweytick
Journal:  Biometals       Date:  2014-05-18       Impact factor: 2.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.